Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,949,472
-$24,558,532 QoQ
Shares Held
873,065
-47.6% QoQ
Ownership
0.982%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 97.82375882666238.ToString("F0")%
Shared 0.ToString("F0")%
None 2.1762411733376097.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Mar 31, 2026CallValue
$1,366,188
CallShares
36,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. LQDA ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
This page
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in LQDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,949,472 | 873,065 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,366,188 | 36,200 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $57,508,004 | 1,667,382 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $4,311,250 | 125,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $33,834,867 | 1,487,901 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,824,629 | 146,439 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,424,516 | 164,374 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $142,260 | 12,097 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $167,376 | 13,948 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $357,304 | 24,224 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $615,190 | 51,138 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $112,788 | 14,368 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $2,084,755 | 478,155 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,510,429 | 349,642 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,796,294 | 368,849 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $475,876 | 172,419 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $416,506 | 145,632 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $125,598 | 46,691 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $106,536 | 36,114 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||